CoreFirst Bank & Trust’s Eli Lilly LLY Stock Holding History

CoreFirst Bank & Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$474K	Sell	515 -85	-14%	-$86.2K	0.25%	72
2025 Q4	$645K	Sell	600 -350	-37%	-$335K	0.35%	61
2025 Q3	$725K	Hold	950	–	–	0.39%	58
2025 Q2	$741K	Hold	950	–	–	0.42%	55
2025 Q1	$785K	Hold	950	–	–	0.5%	51
2024 Q4	$733K	Sell	950 -50	-5%	-$41.4K	0.44%	52
2024 Q3	$886K	Hold	1,000	–	–	0.51%	44
2024 Q2	$905K	Hold	1,000	–	–	0.61%	41
2024 Q1	$778K	Hold	1,000	–	–	0.49%	48
2023 Q4	$583K	Sell	1,000 -200	-17%	-$117K	0.39%	63
2023 Q3	$645K	Hold	1,200	–	–	0.46%	57
2023 Q2	$563K	Hold	1,200	–	–	0.4%	61
2023 Q1	$412K	Hold	1,200	–	–	0.3%	83
2022 Q4	$439K	Hold	1,200	–	–	0.33%	75
2022 Q3	$388K	Hold	1,200	–	–	0.33%	73
2022 Q2	$389K	Buy	1,200 +200	+20%	+$60K	0.31%	75
2022 Q1	$286K	Hold	1,000	–	–	0.2%	109
2021 Q4	$276K	Hold	1,000	–	–	0.18%	114
2021 Q3	$231K	Hold	1,000	–	–	0.16%	120
2021 Q2	$230K	Sell	1,000 -90	-8%	-$18.1K	0.16%	127
2021 Q1	$204K	Buy	1,090 +90	+9%	+$17.6K	0.14%	135
2020 Q4	$169K	Buy	+1,000	New	+$149K	0.13%	138

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CoreFirst Bank & Trust's LLY Position: Q1 2026 in Review

CoreFirst Bank & Trust reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $86.2K and leaving 515 shares worth $474K. The position accounts for 0.25% of the portfolio, ranked #72.

CoreFirst Bank & Trust first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $905K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

CoreFirst Bank & Trust held 515 shares of Eli Lilly worth $474K as of Q1 2026.
CoreFirst Bank & Trust sold 85 Eli Lilly shares in Q1 2026, an estimated $86.2K.
Eli Lilly made up 0.25% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #72 holding.
CoreFirst Bank & Trust first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
CoreFirst Bank & Trust's Eli Lilly position peaked at $905K in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.